ZEUS Scientific Revenue and Competitors
Estimated Revenue & Valuation
- ZEUS Scientific's estimated annual revenue is currently $17M per year.
- ZEUS Scientific's estimated revenue per employee is $340,200
Employee Data
- ZEUS Scientific has 50 Employees.
- ZEUS Scientific grew their employee count by -7% last year.
ZEUS Scientific Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $13.1M | 40 | -5% | N/A | N/A |
#2 | $275.2M | 728 | 28% | N/A | N/A |
#3 | $29.7M | 103 | 10% | N/A | N/A |
#4 | $11050M | 27463 | 4% | $48.1M | N/A |
#5 | $15.8M | 58 | 21% | N/A | N/A |
#6 | $16.5M | 54 | 2% | N/A | N/A |
#7 | $27.8M | 72 | -10% | N/A | N/A |
#8 | $21.9M | 69 | 10% | N/A | N/A |
#9 | $10.8M | 54 | 15% | N/A | N/A |
#10 | $10.4M | 35 | -5% | N/A | N/A |
What Is ZEUS Scientific?
ZEUS Scientific is your first choice for high-performing, easy-to-use clinical diagnostic solutions. Our products are designed and manufactured to ensure optimal efficiency and accurate diagnosis to facilitate better patient care. We offer a wide range of test systems across our core diagnostic areas of autoimmune and infectious disease serology, and are now expanding our menu to include unique predictive cardiac biomarkers and other novel diagnostic tools. The first predictive cardiac biomarker now available from ZEUS is AccuCardia (www.accucardia.com). Numerous scientific studies have established that the enzyme secreted phospholipase A2-IIA (sPLA2-IIA) is an emerging biomarker that plays an important role in inflammation and atherosclerosis. Now sPLA2-IIA can be quickly, easily, and accurately measured from human plasma. It is an advanced, proprietary system that is making cardiovascular risk assessment possible independently from conventional risk markers. Test with confidence. Test with ZEUS.
keywords:N/AN/A
Total Funding
50
Number of Employees
$17M
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $14.1M | 54 | 17% | N/A |
#2 | $10.8M | 57 | 8% | N/A |
#3 | $6M | 59 | 0% | N/A |
#4 | $24.1M | 60 | 5% | N/A |
#5 | $21.1M | 63 | 7% | N/A |